Horton, C., Davies, T., Lahiri, P., Sachamitr, P., & Fairchild, P. (2019). iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy. Wiley.
শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতিHorton, C., TJ Davies, P. Lahiri, P. Sachamitr, এবং PJ Fairchild. IPS Cells Reprogrammed from Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy. Wiley, 2019.
M.L.A (9 ম সংস্করণ) উদ্ধৃতিHorton, C., et al. IPS Cells Reprogrammed from Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy. Wiley, 2019.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.